Target Attainment of TDM-guided Infusion of Piperacillin/Tazobactam and Cefepim in Critically Ill Patients

Clinical trial NCT04530045 · COMPLETED

Trial details

NCT number: NCT04530045
Sponsor: Central Hospital, Nancy, France
Status: COMPLETED
Study type: OBSERVATIONAL

Critical Illness Antibiotic Toxicity Sepsis Septic Shock

Start date: 2018-05-02
Primary completion: 2019-11-01
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.